Alnylam® Pharmaceuticals | Icebreaker

Sign up or Log in

Teams

System

Alnylam® Pharmaceuticals | Icebreaker

Alnylam® Pharmaceuticals

Alnylam® Pharmaceuticals

Learn about Alnylam Pharmaceuticals, RNAi therapeutics, and the company's efforts in treating amyloidosis, hyperoxaluria, and porphyria.

22 members

Contact info

Link

alnylam.com

Members

•

Vice President, Toxicology at Dragonfly Therapeutics, Inc.

•

Regulatory Toxicologist

•

Associate Director, US Market Access at Alnylam Pharmaceuticals

Christopher MacLauchlin

•

Director DMPK at Alnylam Pharmaceuticals

•

Biotech company builder

Emily Shoemaker, EMBA, Ed.M.

•

I’m here to bridge the gaps—between teams, between tech and strategy, and ultimately, between what is and what could be. My career path doesn’t fit neatly in a box. I’ve moved across industries, roles, and continents, from building learning experiences that speak to the individual to guiding data strategies that identify patients overlooked by traditional methods. Along the way, I’ve learned that the real magic happens in the spaces between disciplines, where innovation thrives. I’m a translator of sorts. I speak enough data science to connect with engineers and enough marketing to understand consumer drivers. I know how to create spaces where cross-functional teams stop operating in silos and start collaborating toward something bigger. It’s about fostering alignment, bringing structure to complexity, and creating momentum toward meaningful goals. Every organization faces challenges in staying agile, connected, and focused on the things that matter. I bring the adaptability, cross-functional insight, and operational savvy to help make that happen.

•

Chief Executive Officer at Adimab, LLC

•

Technical Program Manager at Sanmina

•

Experienced Senior Technology Leader with a demonstrated history of working in multiple industries. Strong information technology professional skilled in Business Process, Requirements Analysis, Technology Management, ITIL, and IT Service Management.

•

Over 15+ years of field based marketing experience in all facets of KOL engagement, advocacy development, and demonstrated leadership with innovative initiatives. A strong cross-functional partner and peer leader that coordinates communication and interactions that drive business strategy. Experienced in building scientific/marketing platforms, insight synthesis, advisory boards, speaker management, and securing regulatory approval of unique resources. Successful tenure includes roles in sales, training, and medical affairs within rare disease and biologics including pre-approval market development and several product launches.